Beverly Hills Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$537K Sell
2,821
-150
-5% -$25.8K 0.1% 152
2026
Q1
$502K Hold
2,971
0.08% 184
2025
Q4
$501K Hold
2,971
0.09% 179
2025
Q3
$429K Hold
2,971
0.08% 205
2025
Q2
$376K Hold
2,971
0.07% 219
2025
Q1
$380K Sell
2,971
-1
-0% -$136 0.08% 213
2024
Q4
$393K Buy
2,972
+1,319
+80% +$185K 0.08% 203
2024
Q3
$241K Sell
1,653
-626
-27% -$90.6K 0.05% 301
2024
Q2
$313K Hold
2,279
0.07% 267
2024
Q1
$313K Buy
2,279
+1
+0% +$137 0.07% 267
2023
Q4
$309K Sell
2,278
-216
-9% -$26.4K 0.08% 248
2023
Q3
$305K Sell
2,494
-154
-6% -$19.6K 0.09% 227
2023
Q2
$337K Hold
2,648
0.06% 277
2023
Q1
$342K Buy
2,648
+575
+28% +$75.3K 0.11% 206
2022
Q4
$272K Buy
+2,073
New +$268K 0.12% 190

Other funds holding IBB

Beverly Hills Private Wealth's IBB Position: Q2 2026 in Review

Beverly Hills Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 5% in Q2 2026, selling an estimated $25.8K and leaving 2,821 shares worth $537K. The position accounts for 0.1% of the portfolio, ranked #152.

Beverly Hills Private Wealth first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Beverly Hills Private Wealth held 2,821 shares of iShares Biotechnology ETF worth $537K as of Q2 2026.
  • Beverly Hills Private Wealth sold 150 iShares Biotechnology ETF shares in Q2 2026, an estimated $25.8K.
  • iShares Biotechnology ETF made up 0.1% of Beverly Hills Private Wealth's portfolio in Q2 2026, its #152 holding.
  • Beverly Hills Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Beverly Hills Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.